During the first half of this year 2021, the top 10 selling drugs in the Saudi pharmaceutical market accounted for about 7.2% of the sales of the Saudi drug market, with a sales value of $173.4 million from the sales of the Saudi pharmaceutical market, which amounted to about $2.489 billion during that period.
The top 10 best-selling pharmaceutical brands came in the following order:
1- Rufenac, which is produced by Spimaco Pharmaceutical Company, with sales of $20 million.
2- The drug “Nexium”, produced by AstraZeneca, with sales of $ 20 million.
3- Klavox, which is produced by Spimaco Pharmaceutical Company, with sales of $18.7 million.
4- The drug “Panadol Extra”, produced by GlaxoSmithKline with sales of $ 17.7 million.
5- The drug “Crestor”, which is produced by AstraZeneca, with sales of $ 17.3 million.
6- SAXENDA, a drug produced by Novo Nordisk, with sales of $ 16.9 million.
7- Similac gold 3, which is produced by Abbott Pharmaceuticals, with sales of $ 16.4 million.
8- The drug “Snafi”, which is produced by Spimaco Pharmaceutical Company, with sales of $ 16.3 million.
9- Januvia, which is produced by MSD, with sales of $ 14.6 million.
10- The drug “Gastrozole”, which is produced by the Riyadh Pharma Company, with sales of $ 14.5 million.
